VAERS Explorer
Back to explore

Report #2891771

Received Apr 6, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Cough

Symptom narrative

terrible cough; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of cough in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced cough (Verbatim: terrible cough). The outcome of the cough was not resolved. It was unknown if the reporter considered the cough to be related to Shingrix. It was unknown if the company considered the cough to be related to Shingrix. Additional Information: GSK Receipt Date: 30-MAR-2026 This case was reported by a patient via interactive digital media. The reporter reported a good friend has had a terrible cough for 6 weeks after taking the Shingles shot. The batch number was not provided, and we are unable to contact the reporter.